stockrowAtriCure, Inc. (ATRC) vs STAAR Surgical Company (STAA)
- AtriCure, Inc. ATRC 59.53 −2.86%
- STAAR Surgical Company STAA 25.61 −4.15%
AtriCure, Inc. and STAAR Surgical Company are both Medical Instruments & Supplies companies. AtriCure, Inc. is the larger, with a market value of $3.1B against $1.3B — 2.3× the size. STAAR Surgical Company has negative trailing earnings, so its P/E is not meaningful; AtriCure, Inc. trades at 199×. STAAR Surgical Company grew revenue faster over the last twelve months: 42.4% against 13.8%. AtriCure, Inc. has the higher net margin (2.52% vs 0.16%) and the higher return on invested capital (2.61% vs 0.26%). Across the 20 metrics below, AtriCure, Inc. leads on 11 and STAAR Surgical Company on 9.
Valuation
Profitability
| Metric | ATRC | STAA | Medical Instruments & Supplies median |
|---|---|---|---|
| Gross margin | 76.74% | 73.56% | 53.60% |
| Operating margin | 2.89% | 0.21% | 1.97% |
| Net margin | 2.52% | 0.16% | 0.00% |
| Free cash flow margin | 8.98% | 5.44% | 2.36% |
| Return on equity | 2.95% | 0.15% | 0.00% |
| Return on assets | 2.20% | 0.11% | 0.00% |
| Return on invested capital | 2.61% | 0.26% | 0.13% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack